• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population.

作者信息

Cebrián-Cuenca Ana M, Mata-Cases Manel, Franch-Nadal Josep, Mauricio Dídac, Orozco-Beltrán Domingo, Consuegra-Sánchez Luciano

机构信息

Primary Health Care Center Cartagena Casco, Cartagena, Servicio Murciano de Salud. Calle Maestro Francés, 1. 30201 Cartagena, Murcia, Spain.

Primary Health Care Center La Mina, Gerència d'Àmbit d'Atenció Primària Barcelona Ciutat, Institut Català de la Salut. Plaça Maria Angels Rosell Simplicio, 1. 08930 Sant Adrià de Besòs, Barcelona, Spain.

出版信息

Eur J Prev Cardiol. 2022 Feb 9;28(18):e32-e34. doi: 10.1093/eurjpc/zwaa073.

DOI:10.1093/eurjpc/zwaa073
PMID:33733654
Abstract
摘要

相似文献

1
Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population.根据欧洲心脏病学会/欧洲糖尿病研究学会的标准：来自地中海地区大量人群的数据显示，2型糖尿病患者中有一半处于极高的心血管疾病风险中。
Eur J Prev Cardiol. 2022 Feb 9;28(18):e32-e34. doi: 10.1093/eurjpc/zwaa073.
2
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会（ESC）与欧洲糖尿病研究协会（EASD）合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
3
Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus.推荐的 ESC/EASD 心血管风险分层模型与 SCORE 和 NT-proBNP 作为单一生物标志物在 2 型糖尿病中的风险预测性能比较。
Cardiovasc Diabetol. 2021 Feb 2;20(1):34. doi: 10.1186/s12933-021-01221-w.
4
2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.2013年欧洲心脏病学会/欧洲糖尿病研究学会糖尿病与心血管疾病管理指南：既有知识与证据空白
Diab Vasc Dis Res. 2014 Jan;11(1):5-10. doi: 10.1177/1479164113512859. Epub 2013 Nov 19.
5
[ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].[欧洲心脏病学会与欧洲糖尿病研究协会合作制定的糖尿病、糖尿病前期及心血管系统疾病指南]
Kardiol Pol. 2013;71 Suppl 11:S319-94. doi: 10.5603/KP.2013.0289.
6
Widespread diabetes screening for cardiovascular disease risk estimation.广泛开展糖尿病筛查以评估心血管疾病风险。
Lancet. 2021 Jun 12;397(10291):2228-2230. doi: 10.1016/S0140-6736(21)00764-9. Epub 2021 Jun 2.
7
Addressing Cardiovascular Risk in Diabetes: It's More Than the Sugar.应对糖尿病中的心血管风险：不止于血糖。
Circulation. 2023 Jun 20;147(25):1887-1890. doi: 10.1161/CIRCULATIONAHA.123.065090. Epub 2023 Jun 19.
8
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).与欧洲糖尿病研究协会（EASD）合作制定的欧洲心脏病学会（ESC）糖尿病、糖尿病前期和心血管疾病指南：欧洲心脏病学会（ESC）糖尿病、糖尿病前期和心血管疾病特别工作组与欧洲糖尿病研究协会（EASD）合作制定。
Eur Heart J. 2013 Oct;34(39):3035-87. doi: 10.1093/eurheartj/eht108. Epub 2013 Aug 30.
9
Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study: comment on Nguyen et Al.儿童期血糖稳态变量在预测成人糖尿病及相关心血管代谢危险因素中的效用：博加卢萨心脏研究：对阮等人的评论
Diabetes Care. 2010 Sep;33(9):e123; author reply e124. doi: 10.2337/dc10-0827.
10
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.欧洲心脏病学会（ESC）与欧洲糖尿病研究协会（EASD）合作制定的糖尿病、糖尿病前期和心血管疾病指南——总结
Diab Vasc Dis Res. 2014 May;11(3):133-73. doi: 10.1177/1479164114525548.

引用本文的文献

1
Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study.2型糖尿病合并亚临床甲状腺功能减退患者10年心血管疾病风险的性别差异：一项横断面研究
Front Endocrinol (Lausanne). 2025 Jul 31;16:1635444. doi: 10.3389/fendo.2025.1635444. eCollection 2025.
2
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database.2型糖尿病患者的降脂治疗与低密度脂蛋白目标达成情况：来自意大利糖尿病专科医生协会数据库的趋势
Cardiovasc Diabetol. 2025 Feb 28;24(1):94. doi: 10.1186/s12933-025-02648-1.
3
Long-term efficacy of daily oral semaglutide as add-on or switch therapy in adults with type 2 diabetes: a 12-month real-world retrospective study.
每日口服司美格鲁肽作为成人2型糖尿病附加治疗或转换治疗的长期疗效：一项为期12个月的真实世界回顾性研究。
Acta Diabetol. 2025 Feb 27. doi: 10.1007/s00592-025-02475-6.
4
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain.优化 2 型糖尿病合并高心血管风险或已患心血管疾病人群使用胰高血糖素样肽-1 受体激动剂的障碍与策略：西班牙德尔菲共识。
Adv Ther. 2024 Sep;41(9):3569-3584. doi: 10.1007/s12325-024-02938-2. Epub 2024 Jul 22.
5
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects-A Family Doctor Perspective.具有心血管效应的新型抗糖尿病药物使用率低的原因——家庭医生视角
J Clin Med. 2024 Mar 12;13(6):1617. doi: 10.3390/jcm13061617.
6
To What Extent Does Cardiovascular Risk Classification of Patients with Type 2 Diabetes Differ between European Guidelines from 2023, 2021, and 2019? A Cross-Sectional Study.2023 年、2021 年和 2019 年欧洲指南中，2 型糖尿病患者心血管风险分类在多大程度上存在差异？一项横断面研究。
Medicina (Kaunas). 2024 Feb 16;60(2):334. doi: 10.3390/medicina60020334.
7
A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study.一项关于墨西哥主要在私立诊所就诊的老年2型糖尿病患者心血管疾病患病率的横断面研究。CAPTURE研究。
Diabetol Metab Syndr. 2023 Dec 7;15(1):258. doi: 10.1186/s13098-023-01231-6.
8
Cardiovascular Risk Assessment Among People With Type 2 Diabetes Mellitus in Urban Slums of Central Karnataka, India.印度卡纳塔克邦中部城市贫民窟2型糖尿病患者的心血管风险评估
Cureus. 2023 Oct 8;15(10):e46687. doi: 10.7759/cureus.46687. eCollection 2023 Oct.
9
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes.2型糖尿病患者的全面心血管和肾脏保护
J Clin Med. 2023 Jun 8;12(12):3925. doi: 10.3390/jcm12123925.
10
Telehealth Intervention to Improve Uptake of Evidence-Based Medications among Patients with Type 2 Diabetes and Heart Failure or Cardiovascular Disease.远程医疗干预以提高 2 型糖尿病合并心力衰竭或心血管疾病患者对循证药物的使用
Int J Environ Res Public Health. 2023 Feb 17;20(4):3613. doi: 10.3390/ijerph20043613.